Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer: Potential Biomarkers for Detection?

Pancreas. 2019 Jan;48(1):e1-e3. doi: 10.1097/MPA.0000000000001208.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers / blood*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Fasting / blood*
  • Female
  • Glucagon / blood*
  • Glucose / administration & dosage*
  • Glucose Tolerance Test
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / blood
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / blood
  • Pancreatic Neoplasms / complications
  • Pancreatic Neoplasms / diagnosis*
  • Pioglitazone / therapeutic use

Substances

  • Biomarkers
  • Hypoglycemic Agents
  • Insulin
  • Glucagon
  • Glucose
  • Pioglitazone